gliclazide has been researched along with 3-nitrotyrosine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boggi, U; Bugliani, M; Del Chiaro, M; Del Guerra, S; Del Prato, S; Grupillo, M; Lupi, R; Marchetti, P; Masini, M; Mosca, F; Torri, S; Vistoli, F | 1 |
1 other study(ies) available for gliclazide and 3-nitrotyrosine
| Article | Year |
|---|---|
Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose.
Topics: Antioxidants; Apoptosis; Cells, Cultured; Female; Gliclazide; Glucose; Glyburide; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Microscopy, Electron; Middle Aged; Tyrosine | 2007 |